— Why it moved
Why VTAK Stock Doubled Today — July 8, 2026
Stale patent news met a 2.3-million-share float, and Catheter Precision ran 144% above yesterday's close before giving most of the spike back.
## What moved it A real catalyst, just not a fresh one. On July 6 Catheter Precision announced two new patents, a European grant covering VT ablation targeting from signals stored in pacemakers and defibrillators (part of its VIVO line) plus a second in the Cardionomix heart-failure portfolio. The stock barely reacted that day. It jumped after hours on the 7th, and July 8 was the blow-off.
## The mechanics The float is 2.3 million shares. That's most of the story. It gapped 71% into the bell and 189M shares changed hands, turning the float over roughly 80 times. Two-day-old patent filings don't do that on their own. Momentum does.
## Numbers - Cap: ~$2.6M / float: 2.3M - Day volume: 189M (27x avg) - Prev close: $0.7127 → gap +71% - 52w range: $0.61–$15.68
## Where it ended up Stock Pulse flagged it at 9:25 AM, five minutes before the bell, at $1.22. It hit $1.74 by 10:06, up 43% in 41 minutes, then spent the rest of the session bleeding and closed at $1.346, +10% from the alert and well off the high.
## Reality check - Gave back three quarters of the spike by the close. - Trailing revenue is about $819K against quarterly losses near $1.7M, and February's $36.5M institutional financing keeps the dilution tap on. - Still down 95% from its 52-week high. Second fire in two weeks, and the June 24 run faded too. - This already happened. It explains the move, not a reason to chase it.